Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Comp Physiol A ; 187(3): 171-6, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11401196

RESUMO

Pituitary adenylate cyclase-activating peptide and lysozyme are potent chemorepellents which act through the same receptor in Tetrahymena. Using in vivo behavioral studies, we have found that the pituitary adenylate cyclase-activating peptide/lysozyme receptor appears to signal through a G-protein pathway which is mediated through both adenosine 3'5'monophosphate and protein kinase C. Avoidance to pituitary adenylate cyclase-activating peptide and lysozyme is inhibited by the G-protein inhibitor, guanosine 5'-O-(2thiodiphosphate), the adenosine 3'5'monophate analog, Rp-adenosine-3', 5' cyclic monophosphorothioate, and the protein kinase C inhibitors, calphostin C and bisindolylmaleimide IV. A proposed model for signaling through the pituitary adenylate cyclase-activating peptide/lysozyme receptor is briefly outlined.


Assuntos
AMP Cíclico/farmacologia , Locomoção , Neuropeptídeos/farmacologia , Proteína Quinase C/farmacologia , Tetrahymena thermophila/fisiologia , Animais , Comportamento Animal , Células Quimiorreceptoras , Muramidase/farmacologia , Polipeptídeo Hipofisário Ativador de Adenilato Ciclase
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...